The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Tetrahydrobiopterin as an Alternative Treatment for Mild Phenylketonuria
Open accessAbstract
BACKGROUND: Hyperphenylalaninemia is a common inherited metabolic disease that is due to phenylalanine hydroxylase deficiency, and at least half the affected patients have mild clinical phenotypes. Treatment with a low-phenylalanine diet represents a substantial psychosocial burden, but alternative treatments have not been effective. METHODS: To explore the therapeutic efficacy of tetrahydrobiopterin, we performed a combined phenylalanine-tetrahydrobiopterin loading test and analyzed the in vivo rates of [13C]phenylalanine oxidation in 38 children with phenylalanine hydroxylase deficiency (age range, 1 day to 17 years). We assessed whether responsiveness to tetrahydrobiopterin was associated with specific genotypes, and we mapped mutations using a structural model of the phenylalanine hydroxylase monomer. RESULTS: In 27 (87 percent) of 31 patients with mild hyperphenylalaninemia (10 patients) or mild phenylketonuria (21 patients), tetrahydrobiopterin significantly lowered blood phenylalanine levels. Phenylalanine oxidation was significantly enhanced in 23 of these 31 patients (74 percent). Conversely, none of the seven patients with classic phenylketonuria had a response to tetrahydrobiopterin as defined in this study. Long-term treatment with tetrahydrobiopterin in five children increased daily phenylalanine tolerance, allowing them to discontinue their restricted diets. Seven mutations (P314S, Y417H, V177M, V245A, A300S, E390G, and IVS4-5C-->G) were classified as probably associated with responsiveness to tetrahydrobiopterin, and six mutations (A403V, F39L, D415N, S310Y, R158Q, and I65T) were classified as potentially associated. Four mutations (Y414C, L48S, R261Q, and I65V) were inconsistently associated with this phenotype. Mutations connected to tetrahydrobiopterin responsiveness were predominantly in the catalytic domain of the protein and were not directly involved in cofactor binding. CONCLUSIONS: Tetrahydrobiopterin responsiveness is common in patients with mild hyperphenylalaninemia phenotypes. Responsiveness cannot consistently be predicted on the basis of genotype, particularly in compound heterozygotes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
SWISS‐MODEL and the Swiss‐Pdb Viewer: An environment for comparative protein modeling
Guex, N., & Peitsch, M. C. (1997) · ELECTROPHORESIS · doi:10.1002/elps.1150181505 · Cited by 11,241
Haycock, G. B., Schwartz, G. J., & Wisotsky, D. H. (1978) · The Journal of Pediatrics · doi:10.1016/s0022-3476(78)80601-5 · Cited by 1,675
KACSER, H., & Ja, B. (1973) · PubMed · Cited by 1,455
Tetrahydrobiopterin biosynthesis, regeneration and functions
Thöny, B., Auerbach, G., & Blau, N. (2000) · Biochemical Journal · doi:10.1042/0264-6021:3470001 · Cited by 893
Monogenic traits are not simple: lessons from phenylketonuria
Scriver, C. R., & Waters, P. J. (1999) · Trends in Genetics · doi:10.1016/s0168-9525(99)01761-8 · Cited by 420
Guldberg, P., Rey, F., Zschocke, J., Romano, V., François, B., Michiels, L., Ullrich, K., Hoffmann, G. F., Burgard, P., Schmidt, H., et al. (1998) · The American Journal of Human Genetics · doi:10.1086/301920 · Cited by 353
Ames, B. N., Elson-Schwab, I., & Silver, E. A. (2002) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/75.4.616 · Cited by 319
Tetrahydrobiopterin-responsive phenylalanine hydroxylase deficiency
Kure, S., Hou, D.-C., Ohura, T., Iwamoto, H., Suzuki, S., Sugiyama, N., Sakamoto, O., Fujii, K., Matsubara, Y., & Narisawa, K. (1999) · The Journal of Pediatrics · doi:10.1016/s0022-3476(99)70138-1 · Cited by 299
Panel, N. I. O. H. C. D. (2001) · Pediatrics · doi:10.1542/peds.108.4.972 · Cited by 274
Tetrahydrobiopterin-responsive phenylalanine hydroxylase deficiency
Shintaku, H., Kure, S., Ohura, T., Okano, Y., Ohwada, M., Sugiyama, N., Sakura, N., Yoshida, I., Yoshino, M., Matsubara, Y., et al. (2005) · Zhongguo dangdai erke zazhi · Cited by 254
Cited by
How were new medicines discovered?
Swinney, D. C., & Anthony, J. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3480 · Cited by 1,812
The complete European guidelines on phenylketonuria: diagnosis and treatment
van Wegberg, A. M. J., MacDonald, A., Ahring, K., Bélanger-Quintana, A., Blau, N., Bosch, A. M., Burlina, A., Campistol, J., Feillet, F., Giżewska, M., et al. (2017) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-017-0685-2 · Cited by 830
Self-citationInteractions of Peroxynitrite, Tetrahydrobiopterin, Ascorbic Acid, and Thiols
Kuzkaya, N., Weissmann, N., Harrison, D. G., & Dikalov, S. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m302227200 · Cited by 692
Phenylalanine hydroxylase deficiency
Mitchell, J. J., Trakadis, Y. J., & Scriver, C. R. (2011) · Genetics in Medicine · doi:10.1097/gim.0b013e3182141b48 · Cited by 536
Staessen, J. A., Wang, J., Bianchi, G., & Birkenhäger, W. H. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13302-8 · Cited by 446
ThePAH gene, phenylketonuria, and a paradigm shift
Scriver, C. R. (2007) · Human Mutation · doi:10.1002/humu.20526 · Cited by 336
Waisbren, S. E., Noel, K., Fahrbach, K., Cella, C., Frame, D., Dorenbaum, A., & Levy, H. (2007) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2007.05.006 · Cited by 329
Levy, H. L., Milanowski, A., Chakrapani, A., Cleary, M., Lee, P., Trefz, F. K., Whitley, C. B., Feillet, F., Feigenbaum, A. S., Bebchuk, J. D., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61234-3 · Cited by 320
Blau, N., Hennermann, J. B., Langenbeck, U., & Lichter-Konecki, U. (2011) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2011.08.017 · Cited by 262
Phenylketonuria Scientific Review Conference: State of the science and future research needs
Camp, K. M., Parisi, M. A., Acosta, P. B., Berry, G. T., Bilder, D. A., Blau, N., Bodamer, O. A., Brosco, J. P., Brown, C. S., Burlina, A. B., et al. (2014) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2014.02.013 · Cited by 261
Trefz, F. K., Burton, B. K., Longo, N., Casanova, M. M.-P., Gruskin, D. J., Dorenbaum, A., Kakkis, E. D., Crombez, E. A., Grange, D. K., Harmatz, P., et al. (2009) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2008.11.040 · Cited by 196
Cosentino, F., Hürlimann, D., Delli Gatti, C., Chenevard, R., Blau, N., Alp, N. J., Channon, K. M., Eto, M., Lerch, P., Enseleit, F., et al. (2008) · Heart · doi:10.1136/hrt.2007.122184 · Cited by 143
Second-Generation Pharmacological Chaperones: Beyond Inhibitors
Tran, M. L., Génisson, Y., Ballereau, S., & Dehoux, C. (2020) · Molecules · doi:10.3390/molecules25143145 · Cited by 63
Safety of sapropterin dihydrochloride (6r–bh4) in patients with pulmonary hypertension
Robbins, I. M., Hemnes, A. R., Simon Gibbs, J., Christman, B. W., Howard, L., Meehan, S., Cabrita, I., Gonzalez, R., Oyler, T., Zhao, L., et al. (2011) · Experimental Lung Research · doi:10.3109/01902148.2010.512972 · Cited by 47
Metadata
- Authors
- Muntau, A. C., Röschinger, W., Habich, M., Demmelmair, H., Hoffmann, B., Sommerhoff, C. P., & Roscher, A. A.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2002-12-26
- Volume
- 347
- Issue
- 26
- Pages
- 2122-2132
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2094140621
- Cited by
- 311
- References
- 23
- FWCI
- 8.36
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.